[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556647":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":37,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":43,"sex":49,"minAge":50,"maxAge":7,"enrollmentInfo":51,"targetDuration":7,"studyType":54,"phases":55,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Baystate Medical Center","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"BEHAVIORAL","Talk About It (conversation aid)","\"Talk About It\" is a conversation aid aimed to increase awareness of options and prompt discussion.",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Elizabeth Schoenfeld, MD, MS","CONTACT","4137940000","elizschoen@gmail.com",[20],{"facility":5,"status":21,"city":22,"state":23,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"RECRUITING","Springfield","Massachusetts","01199","United States","US",{"type":28,"coordinates":29},"Point",[30,31],-72.58981,42.10148,{"lat":31,"lon":30},[34],{"name":35,"role":16,"phone":7,"phoneExt":7,"email":36},"Jillian Tozloski","Jillian.Tozloski@baystatehealth.org",{"type":38,"investigatorFullName":39,"investigatorTitle":40,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Elizabeth Schoenfeld, MD","Vice Chair of Research, Department of Emergency Medicine","100556647","aim-2---conversations-can-save-lives-talking-about-buprenorphine--methadone-for-opioid-use-treatment-initiation-100556647",false,"NCT06527820","Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation","Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation (TALK ABOUT It)","TalkAboutIt","Inclusion Criteria:\n\n* Patients aged 16 and older\n* presenting with indications for Medications for Opioid Use Disorder (MOUD) initiation (opioid overdose, opioid withdrawal, complications of injection opioid use, untreated OUD)\n* not currently on buprenorphine or methadone (in the past 7 days).\n\n(Buprenorphine is FDA approved for patients aged 16 and older, so 16- and 17-year-olds may be included with parental consent.)\n\nExclusion Criteria:\n\n* No Opioid Use Disorder (OUD)\n* already on MOUD","ALL","18 Years",{"count":52,"type":53},75,"ESTIMATED","INTERVENTIONAL",[56],"NA","The increasing morbidity and mortality of the opioid epidemic has necessitated a reevaluation of current addiction treatment paradigms: medications for opioid use disorder, such as buprenorphine and methadone, are effective in decreasing one's risk of death and disability from opioid use, but are underutilized and often difficult to access. The 5000 Emergency Departments (EDs) in the US are potential additional locales for medication initiation, but currently only a small minority of ED patients with opioid use disorder are started on medications. This study will refine and pilot an intervention called Talk About It which aims to foster patient-centered care, 'meet patients where they are' for addiction treatment, and increase treatment initiation and adherence via facilitating Shared Decision-Making in the ED around these potentially life-saving options.",[59],"Opioid Use Disorder",[61,62,63,64,65,66],"shared decision-making","decision aid","conversation aid","patient-centered care","addiction","emergency medicine","2024-07-30",{"date":69,"type":70},"2024-07-31","ACTUAL",{"date":72,"type":70},"2024-06-01",{"date":74,"type":53},"2026-08-30",{"name":5,"class":6},1]